Filing Flows › Celldex Therapeutics (CLDX) › Recalls, complaints & regulation
Celldex Therapeutics (CLDX): clinical trials
Celldex Therapeutics (CLDX) beyond its filings: 7 active clinical trials.
Celldex Therapeutics' latest quarter
Celldex Therapeutics, Q2 2026: revenue $22K (-97% year over year), net loss $73.5M, operating cash flow −$57.4M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Celldex Therapeutics have?
7 active studies on ClinicalTrials.gov, 4 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.